Skip to main content
Journal cover image

Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.

Publication ,  Journal Article
Levin, ED; Rezvani, AH; Xiao, Y; Slade, S; Cauley, M; Wells, C; Hampton, D; Petro, A; Rose, JE; Brown, ML; Paige, MA; McDowell, BE; Kellar, KJ
Published in: J Pharmacol Exp Ther
March 2010

Adequate treatment of tobacco addiction remains problematic. Part of the problem with treatment is a poor understanding of the pharmacologic aspects of nicotine contributing to addiction. In addition to activating nicotinic acetylcholine receptors, nicotine also desensitizes them. It is currently not known how much of each of nicotine's actions contribute to its particular behavioral effects. Sazetidine-A (saz-A) is a novel nicotinic receptor-desensitizing agent and partial agonist with high selectivity for alpha4beta2 receptors. The current experiments were conducted to determine whether saz-A would reduce nicotine self-administration in rats and to characterize its ancillary effects. Adult male Sprague-Dawley rats were allowed to self-administer nicotine. After initial food pellet training followed by 10 sessions of nicotine self-administration training, the rats were administered saz-A (0.1-3 mg/kg s.c.) or the saline vehicle in a repeated-measures counterbalanced design. Saz-A at the 3 mg/kg dose significantly decreased nicotine self-administration relative to performance of the same rats after saline injections. In a second study, long-term administration of this dose of sazetidine-A over the course of 10 sessions significantly reduced nicotine self-administration with no apparent diminution of effect. Saz-A in this dose range had only modest effects on locomotor activity, without any overall decrease in activity over a 1-h-long session. Saz-A significantly reduced food self-administration, but this effect was smaller than its effect on nicotine self-administration. Saz-A, which is a selective alpha4beta2-desensitizing agent and partial agonist, effectively reduces nicotine self-administration. This type of treatment holds promise for a new therapy to aid smoking cessation.

Duke Scholars

Published In

J Pharmacol Exp Ther

DOI

EISSN

1521-0103

Publication Date

March 2010

Volume

332

Issue

3

Start / End Page

933 / 939

Location

United States

Related Subject Headings

  • Self Administration
  • Receptors, Nicotinic
  • Rats, Sprague-Dawley
  • Rats
  • Pyridines
  • Pharmacology & Pharmacy
  • Nicotinic Agonists
  • Nicotine
  • Motor Activity
  • Motivation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Levin, E. D., Rezvani, A. H., Xiao, Y., Slade, S., Cauley, M., Wells, C., … Kellar, K. J. (2010). Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. J Pharmacol Exp Ther, 332(3), 933–939. https://doi.org/10.1124/jpet.109.162073
Levin, Edward D., Amir H. Rezvani, Yingxian Xiao, Susan Slade, Marty Cauley, Corinne Wells, Dawn Hampton, et al. “Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.J Pharmacol Exp Ther 332, no. 3 (March 2010): 933–39. https://doi.org/10.1124/jpet.109.162073.
Levin ED, Rezvani AH, Xiao Y, Slade S, Cauley M, Wells C, et al. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. J Pharmacol Exp Ther. 2010 Mar;332(3):933–9.
Levin, Edward D., et al. “Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.J Pharmacol Exp Ther, vol. 332, no. 3, Mar. 2010, pp. 933–39. Pubmed, doi:10.1124/jpet.109.162073.
Levin ED, Rezvani AH, Xiao Y, Slade S, Cauley M, Wells C, Hampton D, Petro A, Rose JE, Brown ML, Paige MA, McDowell BE, Kellar KJ. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. J Pharmacol Exp Ther. 2010 Mar;332(3):933–939.
Journal cover image

Published In

J Pharmacol Exp Ther

DOI

EISSN

1521-0103

Publication Date

March 2010

Volume

332

Issue

3

Start / End Page

933 / 939

Location

United States

Related Subject Headings

  • Self Administration
  • Receptors, Nicotinic
  • Rats, Sprague-Dawley
  • Rats
  • Pyridines
  • Pharmacology & Pharmacy
  • Nicotinic Agonists
  • Nicotine
  • Motor Activity
  • Motivation